Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

365 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Erratum to: A randomized double-blind multi-center trial of hydrogen water for Parkinson's disease: protocol and baseline characteristics.
Yoritaka A, Abe T, Ohtsuka C, Maeda T, Hirayama M, Watanabe H, Saiki H, Oyama G, Fukae J, Shimo Y, Hatano T, Kawajiri S, Okuma Y, Machida Y, Miwa H, Suzuki C, Kazama A, Tomiyama M, Kihara T, Hirasawa M, Shimura H, Hattori N. Yoritaka A, et al. Among authors: hirasawa m. BMC Neurol. 2017 Feb 20;17(1):35. doi: 10.1186/s12883-017-0817-2. BMC Neurol. 2017. PMID: 28219346 Free PMC article. No abstract available.
A randomized double-blind multi-center trial of hydrogen water for Parkinson's disease: protocol and baseline characteristics.
Yoritaka A, Abe T, Ohtsuka C, Maeda T, Hirayama M, Watanabe H, Saiki H, Oyama G, Fukae J, Shimo Y, Hatano T, Kawajiri S, Okuma Y, Machida Y, Miwa H, Suzuki C, Kazama A, Tomiyama M, Kihara T, Hirasawa M, Shimura H, Hattori N. Yoritaka A, et al. Among authors: hirasawa m. BMC Neurol. 2016 May 12;16:66. doi: 10.1186/s12883-016-0589-0. BMC Neurol. 2016. PMID: 27176725 Free PMC article. Clinical Trial.
Randomized, double-blind, multicenter trial of hydrogen water for Parkinson's disease.
Yoritaka A, Ohtsuka C, Maeda T, Hirayama M, Abe T, Watanabe H, Saiki H, Oyama G, Fukae J, Shimo Y, Hatano T, Kawajiri S, Okuma Y, Machida Y, Miwa H, Suzuki C, Kazama A, Tomiyama M, Kihara T, Hirasawa M, Shimura H, Oda E, Ito M, Ohno K, Hattori N. Yoritaka A, et al. Among authors: hirasawa m. Mov Disord. 2018 Sep;33(9):1505-1507. doi: 10.1002/mds.27472. Epub 2018 Sep 12. Mov Disord. 2018. PMID: 30207619 Clinical Trial. No abstract available.
Multiplex families with multiple system atrophy.
Hara K, Momose Y, Tokiguchi S, Shimohata M, Terajima K, Onodera O, Kakita A, Yamada M, Takahashi H, Hirasawa M, Mizuno Y, Ogata K, Goto J, Kanazawa I, Nishizawa M, Tsuji S. Hara K, et al. Among authors: hirasawa m. Arch Neurol. 2007 Apr;64(4):545-51. doi: 10.1001/archneur.64.4.545. Arch Neurol. 2007. PMID: 17420317
Cyclin-dependent kinase 5 is required for normal cerebellar development.
Kumazawa A, Mita N, Hirasawa M, Adachi T, Suzuki H, Shafeghat N, Kulkarni AB, Mikoshiba K, Inoue T, Ohshima T. Kumazawa A, et al. Among authors: hirasawa m. Mol Cell Neurosci. 2013 Jan;52:97-105. doi: 10.1016/j.mcn.2012.10.007. Epub 2012 Oct 18. Mol Cell Neurosci. 2013. PMID: 23085039 Free PMC article.
365 results